Skip to main content
. Author manuscript; available in PMC: 2018 Jun 15.
Published in final edited form as: Oncogene. 2017 Jan 23;36(24):3441–3449. doi: 10.1038/onc.2016.494

Figure 3.

Figure 3

Expression of BCR kinases are maintained by the chaperon function of HSP90. (a) Cells were treated with 0.5 μM PU-H71 for the indicated hours. Protein lysates were probed for BCR signaling molecules. GAPDH, loading control. (b) Cells were treated with PU-H71 at indicated concentrations for 48 h. (c) Cells co-cultured with HS-5 or NKTert were treated with PU-H71 at indicated concentrations for 48 h.